On July 6, 2017, Zur Rose Group AG, the leading "pure play" e-commerce pharmacy in Europe, completed its initial public offering (IPO) and listing on SIX Swiss Exchange (ticker symbol: ROSE / ISIN: CH0042615283) with a total placement volume of CHF 252 million. The base offering consisted of up to 1,806,052 registered shares with a greenshoe option of up to 270,908 registered shares. The trading of the shares on the SIX Swiss Exchange commenced on July 6, 2017. The IPO closed on July 10, 2017 and the option closing occurred on July 17, 2017. The banking syndicate comprised UBS AG and Joh. Berenberg Gossler & Co. KG, who acted as Joint Global Coordinators and Joint Bookrunners, and Zürcher Kantonalbank, who acted as Co-Lead Manager. Neue Helvetische Bank acted as Selling Agent.
Baker McKenzie acted as legal counsel to the banking syndicate. The Baker McKenzie team was led by partner Matthias Courvoisier (Capital Markets) and comprised associates Philip Spoerlé (Capital Markets), Alexander Blaeser (Corporate) and Andrea Bolliger (Tax).